Spinal Cord Compression |
- Back pain, often worse at night and aggravated by coughing or straining.
- Neurological deficits including weakness, sensory loss, and autonomic dysfunction (e.g., bowel or bladder incontinence).
- Common in cancers with vertebral metastases (e.g., breast, lung, prostate).
|
- MRI of the spine is the imaging modality of choice to assess the extent of compression.
- CT scan may be used if MRI is contraindicated.
- Neurological examination to assess the level and severity of spinal cord involvement.
|
- Immediate corticosteroids (e.g., dexamethasone) to reduce swelling and prevent further neurological damage.
- Emergency radiation therapy or surgery depending on the severity and location of the compression.
- Pain management and supportive care, including physical therapy for rehabilitation.
- Consideration of oncological treatment (e.g., chemotherapy) for the underlying malignancy.
|
Superior Vena Cava (SVC) Syndrome |
- Facial swelling, neck vein distension, and upper extremity swelling.
- Dyspnoea, cough, hoarseness, and headache, often worse when bending forward or lying down.
- Commonly associated with lung cancer, lymphoma, or metastatic tumours compressing the SVC.
|
- CT scan of the chest to identify the site of obstruction and evaluate the extent of disease.
- Chest X-ray may show widening of the mediastinum or pleural effusion.
- Venography or MRI may be used in unclear cases to assess the extent of SVC involvement.
|
- Elevate the head of the bed and administer oxygen for symptomatic relief.
- Corticosteroids and diuretics to reduce swelling.
- Radiation therapy or chemotherapy to shrink the tumour causing the obstruction.
- Stent placement in the SVC may be considered in severe or refractory cases.
|
Tumour Lysis Syndrome (TLS) |
- Fatigue, nausea, vomiting, and muscle cramps.
- Signs of acute kidney injury, such as oliguria or anuria.
- Occurs after the initiation of chemotherapy in patients with high tumour burden (e.g., leukaemias, lymphomas).
|
- Laboratory findings include hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia.
- Elevated serum creatinine and blood urea nitrogen (BUN) indicating renal impairment.
- Monitor electrolytes, renal function, and uric acid levels frequently after starting chemotherapy.
|
- Aggressive IV hydration to promote renal excretion of electrolytes and uric acid.
- Allopurinol or rasburicase to prevent or treat hyperuricemia.
- Management of hyperkalemia, hyperphosphatemia, and hypocalcemia with appropriate medications (e.g., insulin, calcium gluconate).
- Dialysis may be necessary in severe cases with refractory electrolyte imbalances or renal failure.
|
Hypercalcemia of Malignancy |
- Nausea, vomiting, constipation, and polyuria.
- Fatigue, weakness, confusion, and possible coma in severe cases.
- Commonly associated with cancers such as breast cancer, lung cancer, and multiple myeloma.
|
- Elevated serum calcium levels (usually >12 mg/dL).
- Low or undetectable parathyroid hormone (PTH) levels.
- ECG may show shortened QT interval and other signs of hypercalcemia.
|
- Aggressive IV hydration with normal saline to enhance renal calcium excretion.
- Bisphosphonates (e.g., zoledronic acid, pamidronate) to inhibit bone resorption.
- Calcitonin may be used for rapid but short-term reduction of calcium levels.
- Treat the underlying malignancy to prevent recurrence of hypercalcemia.
|
Neutropenic Fever |
- Fever (≥38.3°C or ≥38.0°C for more than one hour) in a patient with neutropenia (absolute neutrophil count <500/µL).
- Malaise, chills, and signs of infection, which may be subtle or absent due to neutropenia.
- Often occurs after chemotherapy in patients with hematological malignancies or solid tumours.
|
- Complete blood count showing neutropenia.
- Blood cultures, urine cultures, and chest X-ray to identify potential sources of infection.
- Additional cultures (e.g., from central lines, wounds) based on clinical suspicion.
|
- Immediate empirical broad-spectrum antibiotics (e.g., piperacillin-tazobactam, cefepime) initiated within 1 hour of presentation.
- Consider antifungal therapy if fever persists after 4-7 days of antibiotics and no source is identified.
- Granulocyte colony-stimulating factor (G-CSF) may be used to shorten the duration of neutropenia.
- Close monitoring for signs of sepsis and organ dysfunction, with supportive care as needed.
|
Pericardial Effusion with Cardiac Tamponade |
- Dyspnoea, chest pain, and orthopnea.
- Beck's triad: hypotension, muffled heart sounds, and jugular venous distension.
- May occur due to metastatic involvement of the pericardium, particularly in lung or breast cancer.
|
- Echocardiography showing pericardial effusion with signs of tamponade (e.g., diastolic collapse of the right ventricle).
- Chest X-ray may show an enlarged cardiac silhouette.
- ECG may show low voltage QRS complexes or electrical alternans.
|
- Immediate pericardiocentesis to relieve pressure on the heart.
- IV fluids to maintain blood pressure until definitive treatment.
- Radiation therapy or chemotherapy may be needed to address the underlying malignancy causing the effusion.
- Consider a pericardial window or pericardiectomy for recurrent cases.
|
Septic Shock in Oncology Patients |
- Fever, chills, and signs of infection, such as cough, dysuria, or cellulitis.
- Hypotension, tachycardia, and altered mental status indicating progression to septic shock.
- Commonly associated with immunosuppression due to chemotherapy or hematological malignancies.
|
- Blood cultures, urine cultures, and other relevant cultures before starting antibiotics.
- Serum lactate levels elevated, indicating tissue hypoperfusion.
- Complete blood count (CBC), electrolytes, renal and liver function tests to assess the severity of the shock.
|
- Early goal-directed therapy with IV fluids, broad-spectrum antibiotics, and vasopressors (e.g., norepinephrine) if needed.
- Source control, such as drainage of abscesses or removal of infected devices.
- Monitoring for complications, including organ dysfunction and disseminated intravascular coagulation (DIC).
- Supportive care in an ICU setting for severe cases.
|
Malignant Pleural Effusion |
- Dyspnoea, chest pain, and cough.
- Decreased breath sounds, dullness to percussion, and reduced chest expansion on the affected side.
- Commonly associated with lung cancer, breast cancer, and lymphoma.
|
- Chest X-ray or ultrasound showing fluid in the pleural space.
- CT scan of the chest to evaluate the extent of disease and assess for lung involvement.
- Thoracentesis for pleural fluid analysis, including cytology to confirm malignancy.
|
- Therapeutic thoracentesis to relieve symptoms and improve breathing.
- Chemical pleurodesis (e.g., talc) to prevent recurrence of the effusion.
- Indwelling pleural catheter for recurrent or symptomatic effusions.
- Treat the underlying malignancy with chemotherapy, radiation, or targeted therapy.
|